RET mutations associate with the multiplex endocrine neoplasia type 2 (MEN2) syndrome, which is characterized by the development of medullary thyroid cancer, parathyroid tumors and PCC [35,36]. The gene discussed is RET; the disease is adrenal gland pheochromocytoma.